For Immediate Release

2014.07.31

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Correction to the release titled "Ranbaxy Q1 FY 2015(Apr'14-Jun'14) Sales Rs.23.7 Bn"

With reference to above, we wish to inform you that in the said press release, under the head 'Key Financial Highlights', inadvertently there was a typo error.  The corresponding period for Consolidated sales should be read as "Apr-Jun 2013" instead of "Jan-Mar 2014".

• Consolidated Sales were Rs.23.7 Bn [Apr-Jun 2013: Sales Rs.25.8 Bn].

We regret for the inconvenience caused.

Thanking you,

Yours faithfully,

For Ranbaxy Laboratories Limited

S.K. Patawari

Company Secretary

distributed by